Autor: |
Gollion C; Department of Neurology, University Hospital of Toulouse, Toulouse, France.; INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France., Dupouy J; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Roberts M; Department of Neurology, University Hospital of Toulouse, Toulouse, France., Simonetta-Moreau M; Department of Neurology, University Hospital of Toulouse, Toulouse, France.; INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France., Brefel Courbon C; Department of Neurology, University Hospital of Toulouse, Toulouse, France.; INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France.; Department of Clinical Pharmacology, University Hospital, Toulouse, France., Rascol O; Department of Neurology, University Hospital of Toulouse, Toulouse, France.; INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France.; Department of Clinical Pharmacology, University Hospital, Toulouse, France., Honnorat J; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon - Université Claude Bernard Lyon 1, Lyon, France., Magne FO; Department of Neurology, University Hospital of Toulouse, Toulouse, France.; INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France. |